Page 4 - Erick Rowinsky News Today

Biogen (NASDAQ:BIIB – Get Free Report) issued an update on its FY24 earnings guidance on Wednesday morning. The company provided earnings per share guidance of $15.00-16.00 for the period, compared to the consensus earnings per share estimate of $15.49. The company issued revenue guidance of decline low- to mid-single digits, compared to the consensus revenue […]

Harvest Fund Management Co. Ltd raised its stake in Biogen Inc. (NASDAQ:BIIB – Free Report) by 11.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,290 shares of the biotechnology company’s stock after purchasing an additional 133 shares during the […]

Illinois Municipal Retirement Fund lowered its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 28.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 49,117 shares of the biotechnology company’s stock after selling 19,274 shares during the period. Illinois Municipal […]

Biogen (NASDAQ:BIIB – Free Report) had its price objective reduced by Wedbush from $245.00 to $213.00 in a research report released on Wednesday morning, Benzinga reports. They currently have a neutral rating on the biotechnology company’s stock. Wedbush also issued estimates for Biogen’s Q1 2024 earnings at $3.25 EPS, Q3 2024 earnings at $4.13 EPS, […]

OVERSEA CHINESE BANKING Corp Ltd raised its stake in Biogen Inc. (NASDAQ:BIIB – Free Report) by 6.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,770 shares of the biotechnology company’s stock after purchasing an additional 750 shares during the quarter. […]

OVERSEA CHINESE BANKING Corp Ltd increased its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 6.8% during the 4th quarter, Holdings Channel.com reports. The firm owned 11,770 shares of the biotechnology company’s stock after acquiring an additional 750 shares during the quarter. OVERSEA CHINESE BANKING Corp Ltd’s holdings in Biogen were worth […]

AIA Group Ltd cut its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 8.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,563 shares of the biotechnology company’s stock after selling 141 shares during the period. AIA Group Ltd’s holdings […]

Biogen Inc. (NASDAQ:BIIB – Free Report) – Investment analysts at Wedbush dropped their Q1 2024 earnings per share estimates for Biogen in a report issued on Wednesday, April 17th. Wedbush analyst L. Chico now anticipates that the biotechnology company will post earnings of $3.25 per share for the quarter, down from their prior estimate of […]

Biogen (NASDAQ:BIIB – Get Free Report) had its price objective cut by research analysts at UBS Group from $250.00 to $214.00 in a research report issued on Wednesday, Benzinga reports. The firm presently has a “neutral” rating on the biotechnology company’s stock. UBS Group’s price objective indicates a potential upside of 11.37% from the stock’s […]

Biogen (NASDAQ:BIIB – Get Free Report) had its price objective reduced by analysts at UBS Group from $250.00 to $214.00 in a note issued to investors on Wednesday, Benzinga reports. The brokerage presently has a “neutral” rating on the biotechnology company’s stock. UBS Group’s price objective points to a potential upside of 11.37% from the […]